Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Wendy Chung currently holds 3,562 shares of Prime Medicine, Inc. (PRME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy Chung has been a net neutral trader of PRME stock. They have purchased $0 and sold $0 worth of shares.
Wendy Chung's most recent insider trade was on Sep 16, 2026, when they sold 3,562 shares at $0.00 per share.
Wendy Chung serves as Executive at Prime Medicine, Inc. (PRME). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Wendy Chung holds the position of Executive at Prime Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Wendy Chung has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Wendy Chung was on Sep 16, 2026, when they sold $8.5K worth of RLYB shares. This transaction involved 3,562 shares at $2.38 per share.
Wendy Chung currently owns 3,562 shares of Prime Medicine, Inc. (PRME), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Wendy Chung's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Wendy Chung has 4 Form 4 filings on record as an insider at Prime Medicine, Inc..
Set alerts for Wendy Chung and 40,000+ other insiders.